X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3480) 3480
Publication (304) 304
Newsletter (76) 76
Book Review (33) 33
Magazine Article (19) 19
Newspaper Article (13) 13
Book Chapter (9) 9
Government Document (8) 8
Book / eBook (3) 3
Conference Proceeding (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2997) 2997
male (2843) 2843
prostate cancer (2254) 2254
prostate-specific antigen - blood (1862) 1862
aged (1806) 1806
index medicus (1770) 1770
middle aged (1655) 1655
oncology (1621) 1621
prostate-specific antigen (1315) 1315
cancer (1222) 1222
prostatic neoplasms - pathology (1121) 1121
prostatic neoplasms - drug therapy (1042) 1042
prostatic neoplasms - radiotherapy (999) 999
prostatic neoplasms - blood (990) 990
aged, 80 and over (942) 942
treatment outcome (932) 932
urology & nephrology (916) 916
radiotherapy (835) 835
care and treatment (781) 781
prostate (653) 653
radical prostatectomy (579) 579
radiology, nuclear medicine & medical imaging (571) 571
carcinoma (499) 499
research (498) 498
disease-free survival (495) 495
prostatic neoplasms - mortality (480) 480
chemotherapy (475) 475
follow-up studies (472) 472
prostatic neoplasms - surgery (467) 467
prostatic neoplasms - therapy (460) 460
therapy (444) 444
radiation-therapy (440) 440
neoplasm staging (435) 435
hematology, oncology and palliative medicine (415) 415
prostatectomy (393) 393
retrospective studies (388) 388
health aspects (384) 384
men (382) 382
androgen antagonists - therapeutic use (380) 380
antigens (375) 375
toxicity (369) 369
docetaxel (368) 368
radiotherapy dosage (366) 366
antigen (363) 363
animals (350) 350
survival (349) 349
risk factors (341) 341
analysis (336) 336
urology (332) 332
metastasis (327) 327
prognosis (317) 317
brachytherapy (311) 311
adult (310) 310
patients (310) 310
disease progression (296) 296
time factors (290) 290
antineoplastic combined chemotherapy protocols - therapeutic use (283) 283
trial (281) 281
radiology (278) 278
prostate-specific antigen - metabolism (268) 268
prospective studies (261) 261
clinical trials (258) 258
antineoplastic agents, hormonal - therapeutic use (251) 251
brachytherapy - methods (248) 248
prostatic neoplasms (248) 248
radiation (248) 248
survival analysis (246) 246
medicine & public health (237) 237
radiation therapy (233) 233
mitoxantrone (232) 232
prostatic neoplasms - diagnosis (231) 231
oncology, experimental (228) 228
survival rate (225) 225
risk (222) 222
antineoplastic agents - therapeutic use (220) 220
article (220) 220
radiology and nuclear medicine (217) 217
biomarkers, tumor - blood (215) 215
androgens (214) 214
combined modality therapy (213) 213
adenocarcinoma - drug therapy (207) 207
prednisone (207) 207
mice (202) 202
surgery (200) 200
tumors (200) 200
drug administration schedule (198) 198
taxoids - administration & dosage (198) 198
psa (197) 197
adenocarcinoma (196) 196
prostatic neoplasms - metabolism (194) 194
quality of life (189) 189
neoplasm grading (186) 186
patient outcomes (182) 182
diagnosis (180) 180
adenocarcinoma - blood (179) 179
expression (178) 178
neoplasms (177) 177
pharmacology & pharmacy (171) 171
adenocarcinoma - radiotherapy (170) 170
biopsy (170) 170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3539) 3539
French (20) 20
German (18) 18
Japanese (11) 11
Spanish (6) 6
Hungarian (3) 3
Russian (3) 3
Chinese (2) 2
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 12/2017, Volume 25, Issue 24, pp. 6707 - 6717
Journal Article
CRITICAL REVIEWS IN IMMUNOLOGY, ISSN 1040-8401, 1998, Volume 18, Issue 1-2, pp. 109 - 119
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 72, Issue 3, pp. 792 - 798
Journal Article
Journal Article
EUROPEAN UROLOGY, ISSN 0302-2838, 06/2019, Volume 75, Issue 6, pp. 920 - 926
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is increasingly being used in metastatic castration-resistant prostate cancer... 
RADIATION-DOSIMETRY | prostate cancer | PSMA | MEMBRANE ANTIGEN | Prostate-specific membrane antigen | UROLOGY & NEPHROLOGY | Radioligand therapy | Metastatic castration-resistant | Lutetium
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 95, Issue 1, pp. 435 - 443
Journal Article
European Urology, ISSN 0302-2838, 06/2019, Volume 75, Issue 6, pp. 920 - 926
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is increasingly being used in metastatic castration-resistant prostate cancer... 
Radioligand therapy | Metastatic castration-resistant prostate cancer | Lutetium | Prostate-specific membrane antigen
Journal Article
Anticancer Research, ISSN 0250-7005, 10/2017, Volume 37, Issue 10, pp. 5755 - 5760
Journal Article
Anticancer Research, ISSN 0250-7005, 01/2018, Volume 38, Issue 1, p. 385
Background/Aim: We experienced an unexpected high incidence of gastrointestinal (GI) toxicity in patients undergoing image-guided intensity-modulated... 
Contouring | Immunoglobulins | Medical imaging | Toxicity | Prostate-specific antigen | Bladder | Radiation therapy | Patients | Incidence | Confidence intervals | Reduction | Rectum | Prostate cancer | Prostate | Cancer
Journal Article
Journal of Medical Imaging and Radiation Oncology, ISSN 1754-9477, 08/2019, Volume 63, Issue 4, pp. 538 - 545
Journal Article